Atria Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Atria Investments's MRNA Position: Q2 2026 in Review
Atria Investments opened a new position in Moderna (MRNA) in Q2 2026: 5,614 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #1660 among its holdings. This is a return to the name: Atria Investments previously reported a position in MRNA as recently as Q3 2024.
Atria Investments first reported a position in MRNA in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.06M in Q1 2024. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Atria Investments held 5,614 shares of Moderna worth $393K as of Q2 2026.
- Moderna was a new Atria Investments position in Q2 2026.
- Moderna made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1660 holding.
- Atria Investments first reported a position in Moderna in Q1 2024 and has held it in 4 quarters since.
- Atria Investments's Moderna position peaked at $1.06M in Q1 2024.
- 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.